Joe Rogan’s Trump Jabs, Blockbuster Tech Earnings, and Another Tariff Deadline
Aug 01, 2025•1 hr 19 min•Ep. 639
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Summary
Kara and Scott dive into the proposed ban on congressional stock trading, the implications of Joe Rogan's critiques against President Trump, and the stunning earnings reports from Microsoft and Meta driven by massive AI investments. They also analyze the economic impact of tariffs, the recent Manhattan shooting and gun control debates, and the significant shifts in the weight-loss drug market as Novo Nordisk faces increased competition. The episode concludes with thoughts on Kamala Harris's political future and the highly anticipated Figma IPO.Episode description
Kara and Scott discuss the advancement of a bill to ban stock trading by lawmakers, President Trump’s Joe Rogan problem, and Ghislaine Maxwell agreeing to testify for immunity. Then, President Trump says he will not extend the latest August 1st tariff deadline, and Microsoft and Meta’s mega earnings. Plus, Novo Nordisk shares are plummeting after weak growth for Ozempic and Wegovy.
Watch this episode on the Pivot YouTube channel.
Follow us on Instagram and Threads at @pivotpodcastofficial.
Follow us on Bluesky at @pivotpod.bsky.social.
Follow us on TikTok at @pivotpodcast.
Send us your questions by calling us at 855-51-PIVOT, or at nymag.com/pivot.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
For the best experience, listen in Metacast app for iOS or Android